Author

Ekaterina G. Viktorova

Virginia–Maryland College of Veterinary Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

George A. BeloviD· 3 shared Amy B. Rosenfeld· 2 shared Anna ZiminaiD· 2 shared Diana V. Kouiavskaia· 2 shared Konstantin ChumakoviD· 2 shared Elizabeth Tanner· 1 shared Jeffrey LoubeiD· 1 shared Marcos Florentin· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

George A. BelovORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintJun 11, 2026

Infection-specific long-chain fatty acid metabolism as a broad anti-enterovirus target

Marcos Florentin, Jeffrey Loube, Ekaterina G. Viktorova…·George A. Belov

This study identifies infection-specific long-chain fatty acid metabolism as a broad anti-enterovirus target by showing that polyunsaturated LCFAs inhibit multiple steps of the virus life cycle.

DOI 10.64898/2026.06.10.731372

humanbulk RNA-seq

𝕏 PostBluesky

MicrobiologyVirologyPeer-reviewedMay 19, 2026

Towards the development of a mucosal vectored vaccine against enterovirus D68

Anna Zimina, Ekaterina G. Viktorova, Diana V. Kouiavskaia…·George A. Belov

This paper develops a mucosal vaccine against EVD68 using an NDV vector and evaluates its immunogenicity in mice, finding robust antibody responses but no protection against infection.

DOI 10.1016/j.virol.2026.110960

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintDec 1, 2025

Viral vector-driven trans-encapsidation of replicon RNAs as a rapid approach for the development of safe and economically attractive anti-enterovirus vaccines

Anna Zimina, Diana V. Kouiavskaia, Ekaterina G. Viktorova…·George A. Belov

This paper develops a method using viral vectors to encapsidate replicon RNAs for safe anti-enterovirus vaccines, showing similar efficacy to existing vaccines in mice.

1 citation

mouseexperimental assay

𝕏 PostBluesky